Summit Therapeutics plc Aktie
-
Deine Einschätzung
Was spricht für und gegen Summit Therapeutics plc in den nächsten Jahren?
Pro
Kontra
Rendite von Summit Therapeutics plc im Vergleich
Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
---|---|---|---|---|---|---|---|
Summit Therapeutics plc | - | - | - | - | - | - | - |
Proteome Sciences | 1,89 % | 1,89 % | 5,88 % | -28,95 % | -6,90 % | -14,29 % | 86,21 % |
Oxford BioMedica PLC | -2,02 % | -6,02 % | 23,47 % | 22,22 % | -5,10 % | -14,34 % | -46,16 % |
Sareum Holdings plc | - | 0,60 % | -10,70 % | -50,00 % | -44,70 % | -92,48 % | - |
Kommentare
News

Gäste des Medien- und Thinktank-Gipfels der Shanghai Cooperation Organization besuchen Luoyang: Eintauchen in den dynamischen Puls einer jahrtausendealten Hauptstadt
LUOYANG, China, Aug. 02, 2025 (GLOBE NEWSWIRE) -- Vom 23. bis 27. Juli fand in Zhengzhou, Provinz Henan, der Medien- und Thinktank-Gipfel der Shanghai Cooperation Organization statt. Am 26. Juli

3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results
Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, long-term investors should have a balanced approach to potentially

This Healthcare Stock's Revolutionary Drug Could Make Early Investors Rich
Three years ago, Summit Therapeutics (NASDAQ: SMMT) was a little-known small-cap biotech that few investors with an average tolerance for risk would have bothered to pay attention to at the time